Literature DB >> 7986748

Regulation of vimentin gene transcription in human breast cancer cell lines.

C L Sommers1, J M Skerker, S A Chrysogelos, M Bosseler, E P Gelmann.   

Abstract

We have investigated the control of vimentin expression in human breast cancer cell lines because of its transcriptional activation during malignant progression in breast cancer. Comparison of vimentin-positive (V+) and vimentin-negative (V-) breast cancer cell lines revealed several potential areas of vimentin gene regulation. Analysis of the chromatin structure of the vimentin gene in V+ and V- breast cancer cells showed DNase I hypersensitive sites in the 5' promoter region in V+ cell lines and 3' to the start of transcription in V- cell lines. Promoter deletion and reporter gene analysis revealed the importance of two adjacent AP-1 sites separated by seven GC-rich nucleotides for vimentin expression in V+ breast cancer cells. Mutational analysis of these sequences showed that although both AP-1 sites could bind nuclear proteins from V+ cells in vitro, one AP-1 site was sufficient to drive transcription in CAT reporter gene assays. The GC-rich spacer region had a modulating function on the activity of the AP-1 sites. In addition, levels of c-jun mRNA were elevated in V+ versus V- cells. In summary, distinct sites within the vimentin gene appear to be important for the control of vimentin expression in V+ and V- breast cancer cells with multiple elements acting coordinately to regulate vimentin expression.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7986748

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  10 in total

1.  Identification of a novel vimentin promoter and mRNA isoform.

Authors:  Zhangle Zhou; Søren Kahns; Anders Lade Nielsen
Journal:  Mol Biol Rep       Date:  2009-08-19       Impact factor: 2.316

2.  Sustained c-Jun-NH2-kinase activity promotes epithelial-mesenchymal transition, invasion, and survival of breast cancer cells by regulating extracellular signal-regulated kinase activation.

Authors:  Jinhua Wang; Isere Kuiatse; Adrian V Lee; Jingxuan Pan; Armando Giuliano; Xiaojiang Cui
Journal:  Mol Cancer Res       Date:  2010-02-09       Impact factor: 5.852

3.  miR-375 Regulates Invasion-Related Proteins Vimentin and L-Plastin.

Authors:  Lizandra Jimenez; Jihyeon Lim; Berta Burd; Thomas M Harris; Thomas J Ow; Nicole Kawachi; Thomas J Belbin; Ruth Angeletti; Michael B Prystowsky; Geoffrey Childs; Jeffrey E Segall
Journal:  Am J Pathol       Date:  2017-05-10       Impact factor: 4.307

4.  Modulation of the malignant phenotype of human prostate cancer cells by N-(4-hydroxyphenyl)retinamide (4-HPR).

Authors:  M M Webber; D Bello-DeOcampo; S Quader; N D Deocampo; W S Metcalfe; R M Sharp
Journal:  Clin Exp Metastasis       Date:  1999-05       Impact factor: 5.150

5.  Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells.

Authors:  R Reeves; D D Edberg; Y Li
Journal:  Mol Cell Biol       Date:  2001-01       Impact factor: 4.272

Review 6.  Genes, chromatin, and breast cancer: an epigenetic tale.

Authors:  L M Mielnicki; H L Asch; B B Asch
Journal:  J Mammary Gland Biol Neoplasia       Date:  2001-04       Impact factor: 2.673

7.  ZBP-89 represses vimentin gene transcription by interacting with the transcriptional activator, Sp1.

Authors:  Xueping Zhang; Iman H Diab; Zendra E Zehner
Journal:  Nucleic Acids Res       Date:  2003-06-01       Impact factor: 16.971

8.  Cypripedin diminishes an epithelial-to-mesenchymal transition in non-small cell lung cancer cells through suppression of Akt/GSK-3β signalling.

Authors:  Surassawadee Treesuwan; Boonchoo Sritularak; Pithi Chanvorachote; Varisa Pongrakhananon
Journal:  Sci Rep       Date:  2018-05-22       Impact factor: 4.379

Review 9.  Biomarker Potential of Vimentin in Oral Cancers.

Authors:  Saie Mogre; Vidhi Makani; Swapnita Pradhan; Pallavi Devre; Shyam More; Milind Vaidya; Crismita Dmello
Journal:  Life (Basel)       Date:  2022-01-20

10.  Dexamethasone mediates pancreatic cancer progression by glucocorticoid receptor, TGFβ and JNK/AP-1.

Authors:  Li Liu; Ewa Aleksandrowicz; Frank Schönsiegel; Daniel Gröner; Nathalie Bauer; Clifford C Nwaeburu; Zhefu Zhao; Jury Gladkich; Torsten Hoppe-Tichy; Eitan Yefenof; Thilo Hackert; Oliver Strobel; Ingrid Herr
Journal:  Cell Death Dis       Date:  2017-10-05       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.